BAKER BROS. ADVISORS LP Q1 2020 Filing

Filed May 15, 2020

Portfolio Value

$16.2B

Holdings

110

Report Date

Q1 2020

Filing Type

13F-HR

All Holdings (110 positions)

StockValue
SGENEURSeattle Genetics, Inc.
$5.8B
INCYIncyte Corporation
$2.3B
ACADACADIA Pharmaceuticals Inc.
$1.8B
ONCBeiGene, Ltd.
$1.4B
ALXNAlexion Pharmaceuticals, Inc.
$786.6M
BMRNBioMarin Pharmaceutical Inc.
$641.3M
KODKodiak Sciences Inc.
$552.1M
ASNDAscendis Pharma A/S
$381.8M
1K0IGM Biosciences, Inc.
$176.5M
AMRNAmarin Corporation plc
$138.0M
ARGXargenx SE
$134.3M
NVTA1EURInvitae Corporation
$124.4M
Principia Biopharma Inc.
$116.1M
MRTXEURMirati Therapeutics, Inc.
$108.4M
NBIXNeurocrine Biosciences, Inc.
$107.3M
EXASExact Sciences Corporation
$107.1M
Ra Pharmaceuticals, Inc.
$100.5M
MDGLMadrigal Pharmaceuticals, Inc.
$100.1M
MyoKardia, Inc.
$83.2M
HRTXHeron Therapeutics, Inc.
$70.7M
CERSCerus Corporation
$63.8M
Zymeworks Inc.
$60.6M
1T7Tricida, Inc.
$58.7M
BCELAtreca, Inc.
$58.5M
DBV Technologies S.A.
$57.3M
AXSMAxsome Therapeutics, Inc.
$52.3M
IM8NInsmed Incorporated
$48.5M
KNSAKiniksa Pharmaceuticals, Ltd.
$43.3M
RYTMRhythm Pharmaceuticals, Inc.
$41.2M
KRYSKrystal Biotech, Inc.
$40.9M
NBIX 2.25 05/15/24Neurocrine Biosciences, Inc.
$39.3M
Neoleukin Therapeutics, Inc.
$38.7M
CCXIEURChemoCentryx, Inc.
$34.5M
ALLKGUSDAllakos Inc.
$32.7M
GW Pharmaceuticals plc
$32.5M
AUPHAurinia Pharmaceuticals Inc.
$24.7M
MRUSMerus N.V.
$24.7M
APLSApellis Pharmaceuticals, Inc.
$24.0M
ASMBAssembly Biosciences, Inc.
$22.9M
BCRXBioCryst Pharmaceuticals, Inc.
$21.9M
Frequency Therapeutics, Inc.
$21.0M
ADPTAdaptive Biotechnologies Corporation
$20.7M
ALKSAlkermes plc
$17.9M
QUREuniQure N.V.
$16.9M
BMRN 0.599 08/01/24BioMarin Pharmaceutical Inc.
$15.6M
XNCRXencor, Inc.
$12.8M
URGNUroGen Pharma Ltd.
$12.0M
PTGXProtagonist Therapeutics, Inc.
$11.9M
ADAPYAdaptimmune Therapeutics plc
$10.0M
Aimmune Therapeutics, Inc.
$9.7M
Urovant Sciences Ltd.
$9.2M
MIRMMirum Pharmaceuticals, Inc.
$8.2M
RETAEURReata Pharmaceuticals, Inc.
$8.1M
AGLEUSDAeglea BioTherapeutics, Inc.
$8.0M
IFRXInflarx N.V.
$6.8M
ALECAlector, Inc.
$6.8M
GBYSangamo Therapeutics, Inc.
$6.4M
BioDelivery Sciences International, Inc.
$6.2M
FLGTFulgent Genetics, Inc.
$6.1M
Idera Pharmaceuticals, Inc.
$6.1M
BDQMAlbireo Pharma, Inc.
$6.0M
HZNPHorizon Therapeutics Public Ltd Co
$5.9M
HOOKGBPHOOKIPA Pharma Inc.
$5.8M
OPHTEURIVERIC bio, Inc.
$5.6M
CABACabaletta Bio, Inc.
$4.6M
ArTara Therapeutics, Inc.
$4.6M
Millendo Therapeutics, Inc.
$4.4M
PASGPassage Bio, Inc.
$4.3M
Constellation Pharmaceuticals, Inc.
$4.2M
Immunomedics, Inc.
$4.2M
NERVGBPMinerva Neurosciences, Inc.
$4.1M
Syros Pharmaceuticals, Inc.
$4.1M
CPRXCatalyst Pharmaceuticals, Inc.
$4.1M
Abeona Therapeutics Inc.
$3.3M
ANABAnaptysBio, Inc.
$3.3M
Evofem Biosciences, Inc.
$3.3M
Molecular Templates, Inc.
$3.2M
NGMUSDNGM Biopharmaceuticals, Inc.
$3.1M
ORTXUSDOrchard Therapeutics plc
$3.1M
KRTXKaruna Therapeutics, Inc.
$3.0M
VSAREURAravive, Inc.
$2.8M
TPIVDEURMarker Therapeutics, Inc.
$2.8M
CRNXCrinetics Pharmaceuticals, Inc.
$2.6M
GLPGGalapagos NV
$2.6M
XLRNAcceleron Pharma Inc.
$2.4M
GBTUSDGlobal Blood Therapeutics, Inc.
$2.4M
Harpoon Therapeutics, Inc.
$2.4M
MTNBEURMatinas BioPharma Holdings, Inc.
$2.3M
APLTApplied Therapeutics, Inc.
$2.2M
VKTXViking Therapeutics, Inc.
$2.0M
bluebird bio, Inc.
$1.8M
DNLIDenali Therapeutics Inc.
$1.8M
RCUSArcus Biosciences, Inc.
$1.7M
Menlo Therapeutics Inc.
$1.7M
NTLAIntellia Therapeutics, Inc.
$1.6M
LPTXEURLeap Therapeutics, Inc.
$1.5M
ARYA Sciences Acquisition Corp.
$1.5M
Dicerna Pharmaceuticals, Inc.
$1.5M
Bellicum Pharmaceuticals, Inc.
$1.2M
GTHXEURG1 Therapeutics, Inc.
$970K
Page 1 of 2Next